Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Archives of Gynecology and Obstetrics|November 11, 2016
Pattern of metastatic spread and subcategories of breast cancerCatharina Bartmann, Manfred Wischnewsky, Tanja Stüber, et al.
BMC Cancer|May 14, 2016
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancerJoachim Diessner, Manfred Wischnewsky, Tanja Stüber, et al.
BMC Cancer|July 15, 2016
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patientsRoland Gregor Stein, Daniel Wollschläger, Rolf Kreienberg, et al.
Anti-Cancer Drugs|February 9, 2012
Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitroJörg B Engel, Theresa Martens, Jens C Hahne, et al.
Cancer Research|October 15, 2009
Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cellsFlorian Reim, Yvonne Dombrowski, Cathrin Ritter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2DMathias Krockenberger, Yvonne Dombrowski, Claudia Weidler, et al.
Brain, Behavior, and Immunity|April 14, 2010
Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesisClaudia Heidbrink, Sebastian F M Häusler, Mathias Buttmann, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicitySebastian F M Häusler, Itsaso Montalbán del Barrio, Jenny Strohschein, et al.
Plos One|October 21, 2017
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)Philipp Harter, Jan Hauke, Florian Heitz, et al.
Geburtshilfe Und Frauenheilkunde|December 25, 2018
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast CancerAchim Wöckel, Jasmin Festl, Tanja Stüber, et al.
Pageof 3